🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rebecca Kaltman

Inova Health System

ORCID: 0000-0003-1373-2879

Also affiliated with Inova Fairfax Hospital, Virginia Cancer Institute

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer”.

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003427

N/A

0.500DataRank · unranked

27 citations

Mark G. Woodcock, Amanda E.D. Van Swearingen, Dominic T. Moore, Maria J. Sambade, Sonia J. Laurie +22 more

The Vanguard study: An NCI cancer screening research network multi-cancer detection feasibility study.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e22522

N/A

0.165DataRank · unranked

2 citations

Katherine A. Guthrie, Yikyung Park, Quyen Ngo‐Metzger, Rebecca Kaltman, Carrie B. Lee +4 more

Body composition and chemotherapy toxicity among women treated for breast cancer: a systematic review

Journal of Cancer Survivorship(2023)10.1007/s11764-023-01380-7

N/A

0DataRank · unranked

16 citations

Tom Harrod, Rachel F. Brem, Rebecca Kaltman, Kendall Anderson, Kim Robien +1 more